Previous studies have identified the expression of both TLR-4 and RAGE in cardiomyocytes [8, 48, 49], and genetic deficiency of TLR-4 in cardiomyocytes is known to protect against cardiac dysfunction in endotoxemia [9, 49, 50]. The gene discussed is TLR4; the disease is serum lipopolysaccharide activity.